If you have been struggling with insulin prices, compromising your over health because you cannot afford your medication, Today Eli Lilly is offering you some relief, a new generic insulin on the market at half the price of their most popular brand.
The lower-priced version will be called Insulin Lispro—the same molecule as Humalog—and will be available in vial and pen options. The list price of a single vial will be $ 137.35. The list price of a five-pack of KwikPens will be $ 265.20. Vials and pens of the lower-priced insulin have been manufactured, and Lilly will now work with supply chain partners to make them available in pharmacies as quickly as possible. It will be made available as an authorized generic through a Lilly subsidiary, ImClone Systems. Humalog will also remain available for people who want to continue accessing it through their current insurance plans. Introducing an alternative insulin option allows Lilly to provide a lower-priced insulin more quickly while providing payers time to renegotiate downstream contracts and adjust to new system economics.
If you have Medicare D, this will help with your coverage gap.
If you have any question, call the Lilly Diabetes Solution Center at (833) 808-1234 to learn whether Lilly’s Insulin Lispro, or another option, is the best financial choice for you.
